Evidence map›Paper›PMID 30044874›Full record

ArticlePloS one2018

IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence.

Ellen J Wehrens, Kurt A Wong, Ankan Gupta, Ayesha Khan, Chris A Benedict, Elina I Zuniga

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Cytotoxic CD4Parasite immunology · 2026
    Article
  2. Development of a pediatric immune cell atlas and characterization of CD4+ T cells in food allergy.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Role of IL-27 in HSV-1-Induced Herpetic Stromal Keratitis.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  8. Cytotoxic CD4Frontiers in immunology · 2023
    Review
  9. Article
  10. Review
  11. The Era of Cytotoxic CD4 T Cells.Frontiers in immunology · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. cDC1 IL-27p28 Production Predicts Vaccine-Elicited CD8Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ellen J WehrensDivision of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.ORCID 0000-0003-4307-3181
Kurt A WongDivision of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.
Ankan GuptaDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
Ayesha KhanDivision of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.
Chris A BenedictDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
Elina I ZunigaDivision of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.
University of California San Diego · USLa Jolla Institute for Immunology · US

Funding

Inhibitory Pathways Underlying Viral Persistence In VivoR01AI081923 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Elina I Zuniga · 2009 to 2026
$6.6M
Positive Immune-regulators During Chronic Viral InfectionsR01AI113923 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZUNIGA, ELINA I · 2015 to 2024
$5.1M
The role of TRAIL in immune control of cytomegalovirusR01AI101423 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2013 to 2023
$4.6M
CD4 T cell control of cytomegalovirusR01AI139749 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2019 to 2023
$3.2M
The role of TRAIL in immune control of cytomegalovirusR56AI101423 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2012 to 2012
$435k
NIAID NIH HHS R01 AI081923NIAID NIH HHS R01 AI101423NIAID NIH HHS R01 AI113923NIAID NIH HHS R01 AI139749NIAID NIH HHS R56 AI101423
6 · The paper itself

Abstract

The role of IL-27 in antiviral immunity is still incompletely understood, especially in the context of chronic viruses that induce a unique environment in their infected host. Cytomegalovirus (CMV) establishes a persistent, tissue localized infection followed by lifelong latency. CMV infects the majority of people and although asymptomatic in healthy individuals, can cause serious disease or death in those with naïve or compromised immune systems. Therefore, there is an urgent need to develop a protective CMV vaccine for people at-risk and identifying key regulators of the protective immune response towards CMV will be crucial. Here we studied mouse CMV (MCMV) in IL-27 receptor deficient animals (Il27ra-/-) to assess the role of IL-27 in regulating CMV immunity. We found that IL-27 enhanced the number of antiviral CD4 T cells upon infection. However, in contrast to a well-established role for CD4 T cells in controlling persistent replication and a positive effect of IL-27 on their numbers, IL-27 promoted MCMV persistence in the salivary gland. This coincided with IL-27 mediated induction of IL-10 production in CD4 T cells. Moreover, IL-27 reduced expression of the transcription factor T-bet and restricted a cytotoxic phenotype in antiviral CD4 T cells. This is a highly intriguing result given the profound cytotoxic phenotype of CMV-specific CD4 T cells seen in humans and we established that dendritic cell derived IL-27 was responsible for this effect. Together, these data show that IL-27 regulates the number and effector functions of MCMV-specific CD4 T cells and could be targeted to enhance control of persistent/latent infection.

Indexed as

AnimalsCD4 AntigensCD4-Positive T-LymphocytesHerpesviridae InfectionsInterleukin-10Interleukin-27MiceMice, Inbred C57BLMuromegalovirusSalivary GlandsCD4 AntigensInterleukin-10Interleukin-27

Identifiers

PMID30044874
PMCPMC6059457
OpenAlexW2884527766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.